2.52
price down icon7.35%   -0.20
pre-market  Vorhandelsmarkt:  2.46   -0.06   -2.38%
loading
Schlusskurs vom Vortag:
$2.72
Offen:
$2.71
24-Stunden-Volumen:
23,351
Relative Volume:
0.17
Marktkapitalisierung:
$103.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.92M
KGV:
-8.40
EPS:
-0.3
Netto-Cashflow:
$-7.05M
1W Leistung:
+8.15%
1M Leistung:
+1.20%
6M Leistung:
+142.31%
1J Leistung:
+33.33%
1-Tages-Spanne:
Value
$2.52
$2.7376
1-Wochen-Bereich:
Value
$2.26
$2.7376
52-Wochen-Spanne:
Value
$0.8001
$3.39

Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile

Name
Firmenname
Anebulo Pharmaceuticals Inc
Name
Telefon
737 203 5270
Name
Adresse
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
2025-09-29
Name
Neueste SEC-Einreichungen
Name
ANEB's Discussions on Twitter

Vergleichen Sie ANEB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ANEB
Anebulo Pharmaceuticals Inc
2.52 101.07M 0 -7.92M -7.05M -0.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Anebulo Pharmaceuticals Inc Aktie (ANEB) Neueste Nachrichten

pulisher
12:46 PM

Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Earnings Impact & Daily Market Momentum Tracking - newser.com

12:46 PM
pulisher
12:31 PM

What is the fair value of Anebulo Pharmaceuticals Inc. stock nowPortfolio Return Summary & Expert-Curated Trade Recommendations - newser.com

12:31 PM
pulisher
Oct 15, 2025

Is Anebulo Pharmaceuticals Inc. stock resilient to inflationEarnings Trend Report & Verified Short-Term Trading Plans - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Advanced analytics toolkit walkthrough for Anebulo Pharmaceuticals Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Why Anebulo Pharmaceuticals Inc. stock could see breakout soon2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What technical charts say about Anebulo Pharmaceuticals Inc. stock2025 Market Outlook & Weekly High Momentum Picks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Tick level data insight on Anebulo Pharmaceuticals Inc. volatilityEarnings Miss & Daily Volume Surge Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Will Anebulo Pharmaceuticals Inc. outperform the marketFed Meeting & Risk Managed Investment Strategies - newser.com

Oct 15, 2025
pulisher
Oct 13, 2025

Will Anebulo Pharmaceuticals Inc. price bounce be sustainablePrice Action & Reliable Price Breakout Signals - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 07:20:43 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Price action breakdown for Anebulo Pharmaceuticals Inc.M&A Rumor & Real-Time Volume Trigger Notifications - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Measuring Anebulo Pharmaceuticals Inc.’s beta against major indices2025 Top Decliners & Smart Swing Trading Techniques - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Anebulo approves reverse stock split ahead of going-private transaction - MSN

Oct 10, 2025
pulisher
Oct 09, 2025

Is Anebulo Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Does Anebulo Pharmaceuticals Inc. qualify in momentum factor screeningEarnings Miss & High Return Trade Opportunity Guides - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Anebulo Pharmaceuticals (NASDAQ:ANEB) - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

What drives Anebulo Pharmaceuticals Inc stock priceHigh Beta Stocks & Use Our Sector Rotation Strategy for Gains - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Can Anebulo Pharmaceuticals Inc. recover in the next quarterJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Anebulo Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Regression analysis insights on Anebulo Pharmaceuticals Inc. performanceSell Signal & Smart Allocation Stock Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What institutional flow reveals about Anebulo Pharmaceuticals Inc.Trade Risk Report & Capital Efficiency Focused Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Anebulo Pharmaceuticals Inc. stock attract ESG capital inflowsPrice Action & Stock Market Timing Techniques - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Anebulo Pharmaceuticals Inc. stock continue upward trendWeekly Market Summary & Comprehensive Market Scan Insights - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

Visualizing Anebulo Pharmaceuticals Inc. stock with heatmapsGap Down & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will breakout in Anebulo Pharmaceuticals Inc. lead to full recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Does Anebulo Pharmaceuticals Inc. fit your quant trading model2025 EndofYear Setup & Community Consensus Trade Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Goldman Sachs Group Inc. Invests $62,000 in Anebulo Pharmaceuticals, Inc. $ANEB - Defense World

Oct 02, 2025

Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Kapitalisierung:     |  Volumen (24h):